ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Tripathy Provides an Overview of the SystHERs Registry

Debu Tripathy, MD
Published: Tuesday, Sep 02, 2014

Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, provides an overview of the SystHERs registry.

The SystHERs registry is enrolling patients that have been diagnosed with HER2-positive metastatic breast cancer within 6 months. This represents an effort to collect information on the demographics and treatment history of these patients. Currently, there is no information on how patients are treated after diagnosis.

There is data from individual trials, Tripathy says, which cover one treatment, but the course of treatment and outcomes for these patients is not known.

Debu Tripathy, MD, co-leader, Women's Cancer Program, University of Southern California Norris Comprehensive Cancer Center, provides an overview of the SystHERs registry.

The SystHERs registry is enrolling patients that have been diagnosed with HER2-positive metastatic breast cancer within 6 months. This represents an effort to collect information on the demographics and treatment history of these patients. Currently, there is no information on how patients are treated after diagnosis.

There is data from individual trials, Tripathy says, which cover one treatment, but the course of treatment and outcomes for these patients is not known.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x